These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 24753206

  • 1. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.
    Chok KS, Cheung TT, Lo RC, Chu FS, Tsang SH, Chan AC, Sharr WW, Fung JY, Dai WC, Chan SC, Fan ST, Lo CM.
    Liver Transpl; 2014 Aug; 20(8):912-21. PubMed ID: 24753206
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
    Cheung TT, Poon RT, Jenkins CR, Chu FS, Chok KS, Chan AC, Tsang SH, Dai WC, Yau TC, Chan SC, Fan ST, Lo CM.
    Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
    Li C, Zhang W, Zhang R, Zhang L, Wu P, Zhang F.
    Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations.
    Kim J, Chung DJ, Jung SE, Cho SH, Hahn ST, Lee JM.
    Br J Radiol; 2012 Oct; 85(1018):e940-6. PubMed ID: 22553305
    [Abstract] [Full Text] [Related]

  • 6. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX, Wu PH, Fan WJ, Huang JH, Zhang FJ, Zhang L, Gu YK, Zhao M, Gao F, Jiao DC.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 24; 89(11):754-7. PubMed ID: 19595104
    [Abstract] [Full Text] [Related]

  • 7. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB, Wu F, Wang ZB, Chen WZ, Zhu H.
    Zhonghua Zhong Liu Za Zhi; 2003 Jul 24; 25(4):401-3. PubMed ID: 12921577
    [Abstract] [Full Text] [Related]

  • 8. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
    Wu Y, Li J, Zhang SJ, Zhao YF, Zhao LS, Ma XX, Feng LS, Fan ZJ.
    Zhonghua Wai Ke Za Zhi; 2012 Aug 24; 50(8):691-4. PubMed ID: 23157899
    [Abstract] [Full Text] [Related]

  • 9. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis.
    Jin C, Zhu H, Wang Z, Wu F, Chen W, Li K, Su H, Zhou K, Gong W.
    Eur J Radiol; 2011 Dec 24; 80(3):662-9. PubMed ID: 20864286
    [Abstract] [Full Text] [Related]

  • 10. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ, Rochon PJ, Chang S, Ray CE, Winston H, Ruef R, Kreidler SM, Glueck DH, Shulman BC, Brown AC, Durham J.
    J Vasc Interv Radiol; 2013 Nov 24; 24(11):1613-22. PubMed ID: 24060436
    [Abstract] [Full Text] [Related]

  • 11. Safety of transarterial chemoembolization as bridging therapy in HCC patients with hyperbilirubinemia on the waiting list for liver transplantation: a centre experience.
    Thorat A, Lee CF, Wu TH, Chan KM, Chou HS, Lee WC.
    Hepatogastroenterology; 2013 Nov 24; 60(128):2076-9. PubMed ID: 24719950
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Margreiter R, Vogel W.
    Liver Transpl; 2003 Jun 24; 9(6):557-63. PubMed ID: 12783395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
    Garwood ER, Fidelman N, Hoch SE, Kerlan RK, Yao FY.
    Liver Transpl; 2013 Feb 24; 19(2):164-73. PubMed ID: 23008091
    [Abstract] [Full Text] [Related]

  • 20. Treatment of small hepatocellular carcinomas with US-guided high-intensity focused ultrasound.
    Fukuda H, Ito R, Ohto M, Sakamoto A, Karasawa E, Yamaguchi T, Shinozuka N, Zhu H, Wanga ZB.
    Ultrasound Med Biol; 2011 Aug 24; 37(8):1222-9. PubMed ID: 21645963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.